Vascular Stent Market by Type (BMS, BVS, Drug Eluting), Product (Coronary, Peripheral, Carotid, Femoral, Aortic Aneurysm), Material [Metal (Stainless Steel, PtCr, Nitinol), Polymer], End User (Hospital, Cardiology Center, ASC)- Global Forecast to 2021

Table of Contents

1 INTRODUCTION 19

1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22

2.1 MARKET SIZE ESTIMATION 23
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.3 KEY INDUSTRY INSIGHTS 28
2.4 ASSUMPTIONS FOR THE STUDY 28

3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 33

4.1 VASCULAR STENTS: MARKET OVERVIEW 33
4.2 VASCULAR STENTS MARKET, BY PRODUCT (2016–2021) 33
4.3 VASCULAR STENTS MARKET, BY MODE OF DELIVERY (2016 VS. 2021) 34
4.4 VASCULAR STENTS MARKET, BY MATERIAL (2016 VS. 2021) 34
4.5 PERIPHERAL VASCULAR STENTS MARKET, BY TYPE (2016) 35
4.6 VASCULAR STENTS MARKET, BY END USER (2016 VS. 2021) 36
4.7 GEOGRAPHIC SNAPSHOT: VASCULAR STENTS MARKET 36

5 MARKET OVERVIEW 37

5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
5.2.1 DRIVERS 39
5.2.1.1 Innovations in Stenting Technologies 39
5.2.1.2 Rising Incidence of Vascular Diseases and Subsequent Growth in the Number of Angioplasty Procedures 39
5.2.1.3 Increasing Preference for Minimally Invasive Procedures 40
5.2.1.4 Rapid Growth in the Geriatric Population 40
5.2.2 RESTRAINTS 41
5.2.2.1 Availability of Alternative Treatment Methods for Vascular Diseases 41
5.2.2.2 Product Failures and Recalls 42
5.2.3 OPPORTUNITIES 42
5.2.3.1 Development of Bioresorbable Stents 42
5.2.3.2 Emerging Markets 42
5.2.4 CHALLENGES 43
5.2.4.1 Complications Associated with Stent Implantation 43
5.2.4.2 Declining Costs of Stents 43
5.3 REGULATORY LANDSCAPE 43
5.4 PRODUCT PIPELINE 44

6 VASCULAR STENTS MARKET, BY TYPE 45

6.1 INTRODUCTION 46
6.2 DRUG-ELUTING STENTS 47
6.3 BARE-METAL STENTS 49
6.4 BIOABSORBABLE STENTS 51

7 VASCULAR STENTS MARKET, BY PRODUCT 53

7.1 INTRODUCTION 54
7.2 CORONARY STENTS 55
7.3 PERIPHERAL STENTS 57
7.3.1 CAROTID ARTERY STENTS 60
7.3.2 RENAL ARTERY STENTS 61
7.3.3 FEMORAL ARTERY STENTS 61
7.3.4 ILIAC ARTERY STENTS 62
7.3.5 OTHER PERIPHERAL STENTS 63
7.4 EVAR STENT GRAFTS 63
7.4.1 ABDOMINAL AORTIC ANEURYSM STENTS 65
7.4.2 THORACIC AORTIC ANEURYSM STENTS 66

8 VASCULAR STENTS MARKET, BY MODE OF DELIVERY 67

8.1 INTRODUCTION 68
8.2 BALLOON-EXPANDABLE STENTS 69
8.3 SELF-EXPANDING STENTS 71

9 VASCULAR STENTS MARKET, BY MATERIAL 74

9.1 INTRODUCTION 75
9.2 METALLIC STENTS 76
9.2.1 COBALT CHROMIUM 78
9.2.2 PLATINUM CHROMIUM 79
9.2.3 NICKEL TITANIUM 80
9.2.4 STAINLESS STEEL 81
9.3 OTHER STENTS 82
 

10 VASCULAR STENTS MARKET, BY END USER 84

10.1 INTRODUCTION 85
10.2 HOSPITALS AND CARDIAC CENTERS 86
10.3 AMBULATORY SURGICAL CENTERS 88

11 VASCULAR STENTS MARKET, BY REGION 90

11.1 INTRODUCTION 91
11.2 NORTH AMERICA 92
11.2.1 U.S. 96
11.2.2 CANADA 99
11.3 EUROPE 102
11.3.1 GERMANY 106
11.3.2 FRANCE 108
11.3.3 U.K. 110
11.3.4 REST OF EUROPE 112
11.4 ASIA 116
11.5 REST OF THE WORLD 121

12 COMPETITIVE LANDSCAPE 126

12.1 OVERVIEW 126
12.2 MARKET RANKING ANALYSIS, VASCULAR STENTS MARKET 126
12.3 VENDOR DIVE OVERVIEW 128
12.3.1 VANGUARDS 129
12.3.2 DYNAMIC PLAYERS 129
12.3.3 INNOVATORS 129
12.3.4 EMERGING PLAYERS 129
12.4 BUSINESS STRATEGY (FOR ALL 25 PLAYERS) 130
12.5 PRODUCT OFFERINGS (FOR ALL 25 PLAYERS) 131

*Top 25 companies analyzed for this study are - Abbott Laboratories (U.S.), B. Braun Melsungen AG (Germany), Biosensors International (Singapore), BIOTRONIK SE & Co. KG (Germany), Boston Scientific Corporation (U.S.), Braile Biomédica (Brazil), C. R. Bard (U.S.), Cook Medical (U.S.), Cordis Corporation (U.S.), Endologix, Inc. (U.S.), GRINM Advanced Materials Co., Ltd (China), InSitu Technologies (U.S.), JOTECH GmBH (Germany), Lifetech Scientific Inc. (China), Lombard Medical (U.K.), Medtronic plc (Ireland), Meril Life Sciences (India), Microport Scientifc Corporation (China), OrbusNeich (Hong Kong), S&G Biotech (South Korea), STENTYS S.A. (France), Terumo Corporation (Japan), Translumina GmBH (Germany), Vascular Concepts (India), and W. L. Gore & Associates (U.S.).

13 COMPANY PROFILES 132

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 INTRODUCTION 132
13.2 MEDTRONIC PLC 133
13.3 ABBOTT LABORATORIES 137
13.4 BOSTON SCIENTIFIC CORPORATION 140
13.5 BIOTRONIK SE & CO. KG 144
13.6 B. BRAUN MELSUNGEN AG 147
13.7 TERUMO CORPORATION 150
13.8 MICROPORT SCIENTIFIC CORPORATION 154
13.9 MERIL LIFE SCIENCES PVT. LTD. 159
13.10 VASCULAR CONCEPTS LIMITED 161
13.11 C.R. BARD, INC. 163
13.12 W.L. GORE AND ASSOCIATES, INC. 166
13.13 ENDOLOGIX, INC. 169
13.14 LOMBARD MEDICAL 172
13.15 TRANSLUMINA GMBH 175
13.16 JOTEC GMBH 177

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
14 APPENDIX 179

LIST OF TABLES

TABLE 1 PROJECTED INCREASE IN THE GLOBAL POPULATION BETWEEN
2005 AND 2030, BY AGE 40
TABLE 2 OTHER IMPORTANT MEDICAL DEVICE REGULATIONS 44
TABLE 3 VASCULAR STENTS MARKET: PIPELINE PRODUCTS 44
TABLE 4 VASCULAR STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 46
TABLE 5 COMMERCIALLY AVAILABLE DRUG-ELUTING STENTS 47
TABLE 6 DRUG-ELUTING STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 48
TABLE 7 NORTH AMERICA: DRUG-ELUTING STENTS MARKET, BY COUNTRY,
2014-2021 (USD MILLION) 48
TABLE 8 EUROPE: DRUG-ELUTING STENTS MARKET, BY COUNTRY,
2014-2021 (USD MILLION) 49
TABLE 9 COMMERCIALLY AVAILABLE BARE-METAL STENTS 49
TABLE 10 BARE-METAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 50
TABLE 11 NORTH AMERICA: BARE-METAL STENTS MARKET, BY COUNTRY,
2014-2021 (USD MILLION) 50
TABLE 12 EUROPE: BARE-METAL STENTS MARKET, BY COUNTRY, 2014-2021 (USD MILLION) 50
TABLE 13 BIOABSORBABLE STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 51
TABLE 14 NORTH AMERICA: BIOABSORBABLE STENTS MARKET, BY COUNTRY,
2014-2021 (USD MILLION) 52
TABLE 15 EUROPE: BIOABSORBABLE STENTS MARKET, BY COUNTRY,
2014-2021 (USD MILLION) 52
TABLE 16 VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 54
TABLE 17 CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 55
TABLE 18 CORONARY STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS) 56
TABLE 19 NORTH AMERICA: CORONARY STENTS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 56
TABLE 20 EUROPE: CORONARY STENTS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 56
TABLE 21 GLOBAL PREVALENCE OF PAD, 2010 57
TABLE 22 PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 58
TABLE 23 PERIPHERAL STENTS MARKET SIZE, BY REGION, 2014-2021 (UNITS) 59
TABLE 24 NORTH AMERICA: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 59
TABLE 25 EUROPE: PERIPHERAL STENTS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 59
TABLE 26 PERIPHERAL STENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 60
TABLE 27 CAROTID ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 60
TABLE 28 RENAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 61
TABLE 29 FEMORAL ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 62
TABLE 30 ILIAC ARTERY STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 62
TABLE 31 OTHER PERIPHERAL STENTS MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 63
TABLE 32 EVAR STENT GRAFTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 64
TABLE 33 EVAR STENT GRAFTS MARKET SIZE, BY REGION,
2014-2021 (NO. OF PROCEDURES) 64
TABLE 34 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 64
TABLE 35 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY COUNTRY,
2014-2021 (USD MILLION) 65
TABLE 36 EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 65
TABLE 37 AAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 66
TABLE 38 GLOBAL TAA STENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 66
TABLE 39 VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 68
TABLE 40 COMMERCIALLY AVAILABLE BALLOON-EXPANDABLE VASCULAR STENTS 69
TABLE 41 BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 70
TABLE 42 NORTH AMERICA: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 71
TABLE 43 EUROPE: BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 71
TABLE 44 COMMERCIALLY AVAILABLE SELF-EXPANDING STENTS 72
TABLE 45 SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 72
TABLE 46 NORTH AMERICA: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 72
TABLE 47 EUROPE: SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 73
TABLE 48 VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 75
TABLE 49 METALLIC VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 76
TABLE 50 NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 77
TABLE 51 EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 77
TABLE 52 METALLIC VASCULAR STENTS MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 77
TABLE 53 COMMERCIALLY AVAILABLE COBALT CHROMIUM VASCULAR STENTS 78
TABLE 54 COBALT CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 78
TABLE 55 COMMERCIALLY AVAILABLE PLATINUM CHROMIUM VASCULAR STENTS 79
TABLE 56 PLATINUM CHROMIUM VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 79
TABLE 57 COMMERCIALLY AVAILABLE NICKEL TITANIUM VASCULAR STENTS 80
TABLE 58 NICKEL TITANIUM VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 80
TABLE 59 COMMERCIALLY AVAILABLE STAINLESS STEEL VASCULAR STENTS 81
TABLE 60 STAINLESS STEEL VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 81
TABLE 61 OTHER COMMERCIALLY AVAILABLE VASCULAR STENTS 82
TABLE 62 OTHER VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 82
TABLE 63 NORTH AMERICA: OTHER VASCULAR STENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 83
TABLE 64 EUROPE: OTHER VASCULAR STENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 83
TABLE 65 VASCULAR STENTS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 85
TABLE 66 VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS,
BY REGION, 2014-2021 (USD MILLION) 87
TABLE 67 NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION) 87
TABLE 68 EUROPE: VASCULAR STENTS MARKET SIZE FOR HOSPITALS AND CARDIAC CENTERS, BY COUNTRY, 2014-2021 (USD MILLION) 87
TABLE 69 VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS,
BY REGION, 2014-2021 (USD MILLION) 88
TABLE 70 NORTH AMERICA: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION) 88
TABLE 71 EUROPE: VASCULAR STENTS MARKET SIZE FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2014-2021 (USD MILLION) 89
TABLE 72 VASCULAR STENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 91
TABLE 73 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 92
TABLE 74 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 94
TABLE 75 NORTH AMERICA: PERIPHERAL VASCULAR STENTS MARKET SIZE,
BY TYPE, 2014–2021 (USD MILLION) 94
TABLE 76 NORTH AMERICA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 94
TABLE 77 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 95
TABLE 78 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY, 2014–2021 (USD MILLION) 95
TABLE 79 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 95
TABLE 80 NORTH AMERICA: METALLIC VASCULAR STENTS MARKET SIZE,
BY TYPE, 2014–2021 (USD MILLION) 96
TABLE 81 NORTH AMERICA: VASCULAR STENTS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 96
TABLE 82 U.S.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 97
TABLE 83 U.S.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 98
TABLE 84 U.S.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 98
TABLE 85 U.S.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 98
TABLE 86 U.S.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 99
TABLE 87 CANADA: VASCULAR STENTS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 100
TABLE 88 CANADA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 100
TABLE 89 CANADA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 100
TABLE 90 CANADA: VASCULAR STENTS MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 101
TABLE 91 CANADA: VASCULAR STENTS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 101
TABLE 92 EUROPE: VASCULAR STENTS MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 102
TABLE 93 EUROPE: VASCULAR STENTS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 104
TABLE 94 EUROPE: PERIPHERAL VASCULAR STENTS MARKET SIZE,
BY TYPE, 2014–2021 (USD MILLION) 104
TABLE 95 EUROPE: EVAR STENT GRAFTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 104
TABLE 96 EUROPE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 105
TABLE 97 EUROPE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 105
TABLE 98 EUROPE: VASCULAR STENTS MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 105
TABLE 99 EUROPE: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 106
TABLE 100 EUROPE: VASCULAR STENTS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 106
TABLE 101 GERMANY: VASCULAR STENTS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 107
TABLE 102 GERMANY: VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 107
TABLE 103 GERMANY: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 107
TABLE 104 GERMANY: VASCULAR STENTS MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 108
TABLE 105 GERMANY: VASCULAR STENTS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 108
TABLE 106 FRANCE: VASCULAR STENTS MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 109
TABLE 107 FRANCE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 109
TABLE 108 FRANCE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 109
TABLE 109 FRANCE: VASCULAR STENTS MARKET SIZE, BY MATERIAL,
2014–2021 (USD MILLION) 110
TABLE 110 FRANCE: VASCULAR STENTS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 110
TABLE 111 U.K.: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 111
TABLE 112 U.K.: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 111
TABLE 113 U.K.: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 111
TABLE 114 U.K.: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 112
TABLE 115 U.K.: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 112
TABLE 116 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2007 VS. 2014 (% OF GDP) 113
TABLE 117 ROE: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 114
TABLE 118 ROE: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 114
TABLE 119 ROE: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 114
TABLE 120 ROE: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 115
TABLE 121 ROE: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 115
TABLE 122 ASIA: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 118
TABLE 123 ASIA: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 118
TABLE 124 ASIA: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 118
TABLE 125 ASIA: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 119
TABLE 126 ASIA: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 119
TABLE 127 ASIA: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 119
TABLE 128 ASIA: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 120
TABLE 129 ASIA: VASCULAR STENTS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 120
TABLE 130 ROW: VASCULAR STENTS MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 121
TABLE 131 ROW: PERIPHERAL VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 123
TABLE 132 ROW: EVAR STENT GRAFTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 123
TABLE 133 ROW: VASCULAR STENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 124
TABLE 134 ROW: VASCULAR STENTS MARKET SIZE, BY MODE OF DELIVERY,
2014–2021 (USD MILLION) 124
TABLE 135 ROW: VASCULAR STENTS MARKET SIZE, BY MATERIAL, 2014–2021 (USD MILLION) 124
TABLE 136 ROW: METALLIC VASCULAR STENTS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 125
TABLE 137 ROW: VASCULAR STENTS MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 125
TABLE 138 TOP 3 PLAYERS IN THE VASCULAR STENTS MARKET, 2016 126

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 22
FIGURE 2 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 24
FIGURE 3 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 25
FIGURE 5 DATA TRIANGULATION METHODOLOGY 26
FIGURE 6 KEY DATA FROM SECONDARY SOURCES 27
FIGURE 7 KEY DATA FROM PRIMARY SOURCES 27
FIGURE 8 DRUG-ELUTING STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD 29
FIGURE 9 BALLOON-EXPANDABLE STENTS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 30
FIGURE 10 CORONARY STENTS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD 30
FIGURE 11 HOSPITALS AND CARDIAC CENTERS FORM MAJOR END USERS OF VASCULAR STENTS 31
FIGURE 12 NORTH AMERICA DOMINATED THE VASCULAR STENTS MARKET IN 2016 32
FIGURE 13 RISING BURDEN OF VASCULAR DISEASES AND INNOVATIONS IN STENTING TECHNOLOGIES ARE DRIVING THE MARKET GROWTH FOR VASCULAR STENTS DURING THE FORECAST PERIOD 33
FIGURE 14 CORONARY STENTS DOMINATED THE VASCULAR STENTS MARKET IN 2016 33
FIGURE 15 BALLOON-EXPANDABLE STENTS FORM THE LARGEST MARKET SEGMENT 34
FIGURE 16 METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 34
FIGURE 17 CAROTID STENTS TO DOMINATE THE PERIPHERAL VASCULAR STENTS MARKET DURING THE FORECAST PERIOD 35
FIGURE 18 HOSPITALS AND CARDIAC CENTERS FORMED THE LARGEST END USERS IN 2016 36
FIGURE 19 ASIA TO REGISTER THE HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD 36
FIGURE 20 VASCULAR STENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
FIGURE 21 BIOABSORBABLE STENTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 46
FIGURE 22 ASIA TO GROW AT THE HIGHEST CAGR IN THE DRUG-ELUTING STENTS MARKET DURING THE FORECAST PERIOD 48
FIGURE 23 EVAR STENT GRAFTS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 54
FIGURE 24 ASIA TO GROW AT THE HIGHEST CAGR IN THE PERIPHERAL STENTS MARKET DURING THE FORECAST PERIOD 58
FIGURE 25 BALLOON-EXPANDABLE STENTS TO DOMINATE MARKET FROM 2016 TO 2021 68
FIGURE 26 NORTH AMERICA TO DOMINATE THE BALLOON-EXPANDABLE STENTS MARKET FROM 2016 TO 2021 70
FIGURE 27 METALLIC STENTS TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 75
FIGURE 28 NORTH AMERICA ACCOUNTED FOR THE LARGEST SHARE IN THE METALLIC STENTS MARKET 76
FIGURE 29 HOSPITALS AND CARDIAC CENTERS TO DOMINATE THE VASCULAR STENTS MARKET DURING THE FORECAST PERIOD 85
FIGURE 30 NORTH AMERICA TO DOMINATE THE MARKET FOR HOSPITALS AND CARDIAC CENTERS (2016-2021) 86
FIGURE 31 NORTH AMERICA WILL CONTINUE TO DOMINATE THE GLOBAL VASCULAR STENTS MARKET IN 2021 91
FIGURE 32 NORTH AMERICA: VASCULAR STENTS MARKET SNAPSHOT 93
FIGURE 33 EUROPE: VASCULAR STENTS MARKET SNAPSHOT 103
FIGURE 34 ASIA: VASCULAR STENTS MARKET SNAPSHOT 117
FIGURE 35 ROW: VASCULAR STENTS MARKET SNAPSHOT 122
FIGURE 36 MNM DIVE-VENDOR COMPARISON MATRIX 128
FIGURE 37 GEOGRAPHIC REVENUE MIX OF THE TOP PLAYERS IN THE VASCULAR STENTS MARKET 132
FIGURE 38 MEDTRONIC PLC: COMPANY SNAPSHOT (2016) 133
FIGURE 39 MEDTRONIC PLC: PRODUCT OFFERING SCORECARD 134
FIGURE 40 MEDTRONIC PLC: BUSINESS STRATEGY SCORECARD 134
FIGURE 41 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016) 137
FIGURE 42 ABBOTT LABORATORIES: PRODUCT OFFERING SCORECARD 138
FIGURE 43 ABBOTT LABORATORIES: BUSINESS STRATEGY SCORECARD 138
FIGURE 44 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2016) 140
FIGURE 45 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD 141
FIGURE 46 BOSTON SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD 141
FIGURE 47 BIOTRONIK SE & CO. KG: PRODUCT OFFERING SCORECARD 144
FIGURE 48 BIOTRONIK SE & CO. KG: BUSINESS STRATEGY SCORECARD 145
FIGURE 49 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2016) 147
FIGURE 50 B. BRAUN MELSUNGEN AG: PRODUCT OFFERING SCORECARD 148
FIGURE 51 B. BRAUN MELSUNGEN AG: BUSINESS STRATEGY SCORECARD 148
FIGURE 52 TERUMO CORPORATION: COMPANY SNAPSHOT (2015) 150
FIGURE 53 TERUMO CORPORATION: PRODUCT OFFERING SCORECARD 151
FIGURE 54 TERUMO CORPORATION: BUSINESS STRATEGY SCORECARD 151
FIGURE 55 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015) 154
FIGURE 56 MICROPORT SCIENTIFIC CORPORATION: PRODUCT OFFERING SCORECARD 155
FIGURE 57 MICROPORT SCIENTIFIC CORPORATION: BUSINESS STRATEGY SCORECARD 155
FIGURE 58 MERIL LIFE SCIENCES PVT. LTD: PRODUCT OFFERING SCORECARD 159
FIGURE 59 MERIL LIFE SCIENCES PVT. LTD: BUSINESS STRATEGY SCORECARD 159
FIGURE 60 VASCULAR CONCEPTS LIMITED: PRODUCT OFFERING SCORECARD 161
FIGURE 61 VASCULAR CONCEPTS LIMITED: BUSINESS STRATEGY SCORECARD 161
FIGURE 62 C.R. BARD, INC.: COMPANY SNAPSHOT (2016) 163
FIGURE 63 C.R. BARD: PRODUCT OFFERING SCORECARD 164
FIGURE 64 C.R. BARD: BUSINESS STRATEGY SCORECARD 164
FIGURE 65 W. L. GORE & ASSOCIATES, INC.: PRODUCT OFFERING SCORECARD 166
FIGURE 66 W. L. GORE & ASSOCIATES, INC.: BUSINESS STRATEGY SCORECARD 167
FIGURE 67 ENDOLOGIX, INC.: COMPANY SNAPSHOT (2016) 169
FIGURE 68 ENDOLOGIX, INC.: PRODUCT OFFERING SCORECARD 170
FIGURE 69 ENDOLOGIX, INC.: BUSINESS STRATEGY SCORECARD 170
FIGURE 70 LOMBARD MEDICAL: COMPANY SNAPSHOT (2015) 172
FIGURE 71 LOMBARD MEDICAL: PRODUCT OFFERING SCORECARD 173
FIGURE 72 LOMBARD MEDICAL: BUSINESS STRATEGY SCORECARD 173
FIGURE 73 TRANSLUMINA GMBH: PRODUCT OFFERING SCORECARD 175
FIGURE 74 TRANSLUMINA: BUSINESS STRATEGY SCORECARD 175
FIGURE 75 JOTEC GMBH: PRODUCT OFFERING SCORECARD 177
FIGURE 76 JOTEC GMBH: BUSINESS STRATEGY SCORECARD 177

当レポートのプレスリリースは発行されておりません。